David Davies
Director of Finance/CFO at DName-iT NV
Net worth: 192 $ as of 2024-06-29
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Harry Cuppens | M | - |
DName-iT NV
 DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | 10 years |
| Ilian Iliev | M | 48 |
DName-iT NV
DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | - |
| Charles Maria Jonscher | M | 70 |
DName-iT NV
DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | - |
| Don Daley | M | - |
DName-iT NV
DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | - |
| Tony Baxter | M | - |
DName-iT NV
DName-iT NV BiotechnologyHealth Technology DName-IT NV engages in the research and development of genetic diagnostic tests. It offers D name molecules, accessory consumables, and software for improving the quality of workflow of genetic diagnostic tests based on next generation sequencing. The company was founded by Harry Cuppens on December 11, 2014 and is headquartered in Leuven, Belgium. | - |
Connections Chart
Multi-company connection
Statistics
| Country | Connections | % of total |
|---|---|---|
| Belgium | 5 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- David Davies
- Personal Network
